Skip to main content

Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status

European Journal of Nuclear Medicine and Molecular Imaging volume 38, pages 1580–1581 (2011)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Mansi L, Virgolini I. Diagnosis and therapy are walking together on radiopeptides’ avenue. Eur J Nucl Med Mol Imaging 2011;38:605–12.

    PubMed  Article  Google Scholar 

  2. Vegt E, Melis M, Eek A, de Visser M, Brom M, Oyen WJ, et al. Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice. Eur J Nucl Med Mol Imaging 2011;38:623–32.

    PubMed  Article  CAS  Google Scholar 

  3. Çiçek E, Yildiz M, Delibaş N, Bahçeli S. The effects of thyroid scintigraphy studies on oxidative damage in patients. Acta Physiol Hung 2006;93:131–6.

    PubMed  Article  Google Scholar 

  4. Çiçek E, Yildiz M, Delibas N, Bahçeli S. The effects of 201Tl myocardial perfusion scintigraphy studies on oxidative damage in patients. West Indian Med J 2009;58:50–3.

    PubMed  Google Scholar 

  5. Reeves MA, Hoffmann PR. The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 2009;66:2457–78.

    PubMed  Article  CAS  Google Scholar 

  6. Last KW, Cornelius V, Delves T, Sieniawska C, Fitzgibbon J, Norton A, et al. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin’s lymphoma. J Clin Oncol 2003;21:2335–41.

    PubMed  Article  Google Scholar 

  7. Moncayo R, Kroiss A, Oberwinkler M, Karakolcu F, Starzinger M, Kapelari K, et al. The role of selenium, vitamin C, and zinc in benign thyroid diseases and of selenium in malignant thyroid diseases: low selenium levels are found in subacute and silent thyroiditis and in papillary and follicular carcinoma. BMC Endocr Disord 2008;8:2.

    PubMed  Article  Google Scholar 

  8. Demir M, Konukoğlu D, Kabasakal L, Yelke HK, Ergen K, Ahmed S. The effects of exposure of 60Co on the oxidant/antioxidant status among radiation victims. J Environ Radioact 2003;64:19–25.

    PubMed  Article  Google Scholar 

  9. Knizhnikov VA, Shandala NK, Komleva VA, Knyazhev M, Tutelyan VA. The effect of dietary levels of selenium on radiation resistance and radiation-induced carcinogenesis. Nutr Res 1996;16:505–16.

    Article  CAS  Google Scholar 

  10. Olson GE, Winfrey VP, Hill KE, Burk RF. Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells. J Biol Chem 2008;283:6854–60.

    PubMed  Article  CAS  Google Scholar 

  11. Moncayo R. Cubilin and megalin in radiation-induced renal injury with labelled somatostatin analogues: are we just dealing with the kidney? Eur J Nucl Med Mol Imaging 2005;32:1131–5.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria

    Roy Moncayo & Annette Traeger

Authors
  1. Roy Moncayo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annette Traeger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roy Moncayo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Moncayo, R., Traeger, A. Decreased selenium levels after peptide receptor radionuclide therapy (PRRT) in patients with neuroendocrine tumours: implications for the antioxidant status. Eur J Nucl Med Mol Imaging 38, 1580–1581 (2011). https://doi.org/10.1007/s00259-011-1839-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-011-1839-4

Keywords

  • Selenium
  • Glutathione Peroxidase
  • Octreotide
  • Neuroendocrine Tumour
  • Selenium Level